Your browser doesn't support javascript.
loading
Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium.
Truong, Thérèse; Lesueur, Fabienne; Sugier, Pierre-Emmanuel; Guibon, Julie; Xhaard, Constance; Karimi, Mojgan; Kulkarni, Om; Lucotte, Elise A; Bacq-Daian, Delphine; Boland-Auge, Anne; Mulot, Claire; Laurent-Puig, Pierre; Schvartz, Claire; Guizard, Anne-Valérie; Ren, Yan; Adjadj, Elisabeth; Rachédi, Frédérique; Borson-Chazot, Francoise; Ortiz, Rosa Maria; Lence-Anta, Juan J; Pereda, Celia María; Comiskey, Daniel F; He, Huiling; Liyanarachchi, Sandya; de la Chapelle, Albert; Elisei, Rossella; Gemignani, Federica; Thomsen, Hauke; Forsti, Asta; Herzig, Anthony F; Leutenegger, Anne-Louise; Rubino, Carole; Ostroumova, Evgenia; Kesminiene, Ausrele; Boutron-Ruault, Marie-Christine; Deleuze, Jean-François; Guénel, Pascal; de Vathaire, Florent.
Afiliação
  • Truong T; University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Team "Exposome and Heredity", Villejuif, France.
  • Lesueur F; Inserm, U900, Institut Curie, PSL University, Mines ParisTech, Paris, France.
  • Sugier PE; University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Team "Exposome and Heredity", Villejuif, France.
  • Guibon J; University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Team "Exposome and Heredity", Villejuif, France.
  • Xhaard C; Inserm, U900, Institut Curie, PSL University, Mines ParisTech, Paris, France.
  • Karimi M; University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Team "Epidemiology of radiations", Villejuif, France.
  • Kulkarni O; University of Lorraine, INSERM CIC 1433, Nancy CHRU, Inserm U1116, FCRIN, INI-CRCT, Nancy, France.
  • Lucotte EA; University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Team "Exposome and Heredity", Villejuif, France.
  • Bacq-Daian D; Inserm, U900, Institut Curie, PSL University, Mines ParisTech, Paris, France.
  • Boland-Auge A; University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Team "Exposome and Heredity", Villejuif, France.
  • Mulot C; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France.
  • Laurent-Puig P; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, Evry, France.
  • Schvartz C; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC, Université Paris Descartes, Université Paris Diderot, EPIGENETEC, Paris, France.
  • Guizard AV; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC, Université Paris Descartes, Université Paris Diderot, EPIGENETEC, Paris, France.
  • Ren Y; Registre des Cancers Thyroïdiens, Institut GODINOT, Reims, France.
  • Adjadj E; Registre Général des tumeurs du Calvados, Centre François Baclesse, Caen, France.
  • Rachédi F; Inserm U1086 -UCN "ANTICIPE", Caen, France.
  • Borson-Chazot F; University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Team "Epidemiology of radiations", Villejuif, France.
  • Ortiz RM; University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Team "Epidemiology of radiations", Villejuif, France.
  • Lence-Anta JJ; Endocrinology Unit, Territorial Hospital Taaone, Papeete, Tahiti, French Polynesia.
  • Pereda CM; Fédération d'endocrinologie, Hôpital Louis Pradel, Hospices Civils de Lyon, EA 7425, Université Lyon 1, Lyon, France.
  • Comiskey DF; Institute of Oncology and Radiobiology, La Havana, Cuba.
  • He H; Institute of Oncology and Radiobiology, La Havana, Cuba.
  • Liyanarachchi S; Institute of Oncology and Radiobiology, La Havana, Cuba.
  • de la Chapelle A; Human Cancer Genetics Program and Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
  • Elisei R; Human Cancer Genetics Program and Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
  • Gemignani F; Human Cancer Genetics Program and Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
  • Thomsen H; Human Cancer Genetics Program and Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
  • Forsti A; Endocrine Unit, University Hospital of Pisa, Pisa, Italy.
  • Herzig AF; Department of Biology, University of Pisa, Pisa, Italy.
  • Leutenegger AL; Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Rubino C; GeneWerk GmbH, Heidelberg, Germany.
  • Ostroumova E; Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kesminiene A; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Boutron-Ruault MC; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Deleuze JF; Inserm, U1078, GGB, Université de Bretagne Occidentale, EFS, Brest, France.
  • Guénel P; Université de Paris, NeuroDiderot, Inserm, U1141, Paris, France.
  • de Vathaire F; University Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Team "Epidemiology of radiations", Villejuif, France.
Int J Cancer ; 148(12): 2935-2946, 2021 06 15.
Article em En | MEDLINE | ID: mdl-33527407
Incidence of differentiated thyroid carcinoma (DTC) varies considerably between ethnic groups, with particularly high incidence rates in Pacific Islanders. DTC is one of the cancers with the highest familial risk suggesting a major role of genetic risk factors, but only few susceptibility loci were identified so far. In order to assess the contribution of known DTC susceptibility loci and to identify new ones, we conducted a multiethnic genome-wide association study (GWAS) in individuals of European ancestry and of Oceanian ancestry from Pacific Islands. Our study included 1554 cases/1973 controls of European ancestry and 301 cases/348 controls of Oceanian ancestry from seven population-based case-control studies participating to the EPITHYR consortium. All participants were genotyped using the OncoArray-500K Beadchip (Illumina). We confirmed the association with the known DTC susceptibility loci at 2q35, 8p12, 9q22.33 and 14q13.3 in the European ancestry population and suggested two novel signals at 1p31.3 and 16q23.2, which were associated with thyroid-stimulating hormone levels in previous GWAS. We additionally replicated an association with 5p15.33 reported previously in Chinese and European populations. Except at 1p31.3, all associations were in the same direction in the population of Oceanian ancestry. We also observed that the frequencies of risk alleles at 2q35, 5p15.33 and 16q23.2 were significantly higher in Oceanians than in Europeans. However, additional GWAS and epidemiological studies in Oceanian populations are needed to fully understand the highest incidence observed in these populations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Polimorfismo de Nucleotídeo Único / População Branca / Havaiano Nativo ou Outro Ilhéu do Pacífico / Estudo de Associação Genômica Ampla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Oceania Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Polimorfismo de Nucleotídeo Único / População Branca / Havaiano Nativo ou Outro Ilhéu do Pacífico / Estudo de Associação Genômica Ampla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Oceania Idioma: En Ano de publicação: 2021 Tipo de documento: Article